Dose Imaging Detectors for Radiotherapy Based on Gas Electron Multipliers

Information

  • Research Project
  • 7745423
  • ApplicationId
    7745423
  • Core Project Number
    R43CA137917
  • Full Project Number
    1R43CA137917-01A1
  • Serial Number
    137917
  • FOA Number
    PA-08-050
  • Sub Project Id
  • Project Start Date
    7/1/2009 - 15 years ago
  • Project End Date
    2/28/2010 - 14 years ago
  • Program Officer Name
    BEYLIN, DAVID M
  • Budget Start Date
    7/1/2009 - 15 years ago
  • Budget End Date
    2/28/2010 - 14 years ago
  • Fiscal Year
    2009
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    6/29/2009 - 15 years ago
Organizations

Dose Imaging Detectors for Radiotherapy Based on Gas Electron Multipliers

DESCRIPTION (provided by applicant): In this SBIR project, PartTec will develop a detector that can support the high precision requirements of Intensity Modulated Proton Therapy, the next-generation Proton Therapy. There are no detectors currently available that meet the design goals of this project, in particular high spatial and timing resolution. While efforts have been started in this area, there is no commercially available alternative to the detector anticipated by this proposal. Proton therapy has been offered with ever-increasing precision for more than 40 years. Proton therapy provides superior tumor control and vastly diminishes post-treatment side effects when compared to conventional external beam therapies, surgery and chemotherapy. Because of these substantial benefits, proton therapy is an important radiation therapy treatment option. Most solid tumors, particularly those located near critical structures, can be treated with proton therapy. The superior dose distribution of proton therapy allows treatment for patients for whom there was previously no option such as patients with recurrent cancers or patients who can no longer tolerate other therapies. Approximately 50% of children treated with proton therapy have reduced incidence of secondary malignancies and reduced risk of neuropsychologic and intellectual deficits. The proposed project is highly focused on producing a detector that will meet current needs of the Oncologists, Medical Physicists, Dosimetrists and Therapists who are delivering Proton Therapy to their patients. The next step in the Development of Proton Therapy is the Intensity Modulated Proton Therapy (IMPT). This innovation uses "pencil beam" scanning of the Proton Beam across the tumor, from one side to the other and from top to bottom. At the same time, the depth of the beam penetration is controlled, enabling its energy to be deposited into very small three-dimensional voxels within the tumor. Conventional Proton Therapy facilities with passive beam spreading and uniform scanning beams will also benefit from development of new, high precision detectors for on-line beam monitoring and quality assurance. In Phase I of this proposal PartTec will develop an innovative position sensitive Gas Electron Multiplier (GEM) detector system for two-dimensional dose imaging in particle therapy. PartTec believes such detectors will be capable of providing linear response, better than one millimeter spatial resolution, microsecond time resolution, and accurate reproduction of the Bragg peak shape if used as depth dose profilers. The GEM offers fast performance, robustness and flexibility in the detector design, allowing for various pickup electrode layouts and the option to cascade GEMs in order to improve the signal to noise ratio. Depending on the measurement requirements, 2D readout will be performed with either a CCD camera or segmented pickup electrodes and charge-integrating front-end electronics. In Phase II of this proposal, PartTec's research will be extended to include the depth dose (3D) profiling capabilities o such a detector. PUBLIC HEALTH RELEVANCE: All Medical Providers want to provide their patients with the best, most precise and safe cancer treatments available. The hope is for radiotherapy that destroys cancer cells while avoiding injury to non-cancerous cells. Proton Therapy, especially Intensity Modulated Proton Therapy (IMPT), offers that hope. Along with development of treatment delivery methods, there is the need for a new generation of detectors that monitor and report the precise alignment of the proton beam. In this SBIR project, PartTec, Ltd. will develop such a beam detector that will expand and improve overall treatment options for the public.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    177826
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
    NCI:177826\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PARTTEC, LTD
  • Organization Department
  • Organization DUNS
    123749181
  • Organization City
    BLOOMINGTON
  • Organization State
    IN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    47404
  • Organization District
    UNITED STATES